Over the last two decades, the Beckley Foundation and other researchers around the world have generated a body of compelling data that show how psychedelic compounds represent new treatment opportunity for neuropsychiatric conditions.
Beckley Psytech was created to build upon this body of promising scientific evidence, with the goal of taking a pipeline of psychedelic compounds through pharmaceutical development and onto people in need.
Links to other websites do not imply affiliation or endorsement. Beckley Psytech does not control and is not responsible for their content.
